Dr. Gottesdiener is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Rhythm Pharmaceuticals
855 Boylston Street, 11th Floor
Boston, MA 02116Phone+1 857-264-4280
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1985 - 1988
Brigham and Women's HospitalResidency, Internal Medicine, 1982 - 1985
Perelman School of Medicine at the University of PennsylvaniaClass of 1982
Certifications & Licensure
CT State Medical License 1985 - 2026
NY State Medical License 1988 - 2026
MA State Medical License 1984 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 48 citationsMelanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist TreatmentKristin L. Ayers, Benjamin S. Glicksberg, Alastair S Garfield, Simonne Longerich, Joseph A White
The Journal of Clinical Endocrinology and Metabolism. 2018-07-01 - 194 citationsMC4R agonism promotes durable weight loss in patients with leptin receptor deficiencyKarine Clément, Heike Biebermann, I. Sadaf Farooqi, Lex H.T. Van der Ploeg, Barbara Wolters
Nature Medicine. 2018-05-01 - 98 citationsEfficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled StudyMichael Camilleri, Richard W. McCallum, Jan Tack, Sharon C. Spence, Keith Gottesdiener
Gastroenterology. 2017-11-01
Press Mentions
Prime Medicine Appoints Ann L. Lee as Chief Technical OfficerOctober 13th, 2021- Chutes & Ladders—Biogen CFO Capello Steps down from Role Amid M&A SpeculationJuly 24th, 2020
- A Wobbly Biogen Makes a Surprise Switch in the Executive Suite, Triggering a Renewed Burst of M&A ChatterJuly 22nd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
